Mount Sinai halts minor gender reassignment procedures following federal agreement

Mount Sinai Hospital, a prominent medical institution in New York City, will discontinue providing sex reassignment procedures to minors. This decision comes after the hospital reached an agreement with the Trump administration, marking a significant development in the national discourse surrounding gender-affirming care for young patients.

The resolution includes a financial penalty for the hospital and mandates a substantial investment of $2 million to fund free medical services for individuals who have experienced adverse effects from transgender treatments received during their childhood. This initiative is part of a broader Justice Department inquiry targeting medical institutions offering such procedures to minors across the country.

Federal scrutiny intensifies over pediatric gender transitions

The Department of Justice (DOJ) has affirmed its commitment to holding medical providers accountable for practices deemed to violate federal law and potentially endanger children through gender-affirming care. Attorney General Todd Blanche stated that this agreement with Mount Sinai effectively ends these specific practices at the facility and offers crucial relief to individuals who have already suffered harm. This action underscores a growing federal focus on the medical protocols surrounding gender transition for young people.

Assistant Attorney General Brett Shumate of the Civil Division emphasized that a rising number of hospitals, including Mount Sinai, are acknowledging what he termed the “medical scandal” of sex-rejecting procedures. He added that while the DOJ welcomes resolutions that cease these practices and protect children, the department remains steadfast in its pursuit of justice for all affected individuals. Curbing sex reassignment procedures for minors has been a top priority for the Trump administration, reflecting a broader policy shift in this area.

DOJ’s investigation targets alleged legal violations

The Justice Department’s ongoing investigation into hospitals providing gender transition procedures to minors examines potential violations of several federal statutes. These include scrutiny under the Food, Drug, and Cosmetic Act, the False Claims Act, and other federal healthcare laws. The inquiry specifically looks into alleged fraudulent billing practices, such as the use of incorrect diagnosis codes to secure payments from federal healthcare programs and private insurers.

The agreement reached with Mount Sinai is the latest in a series of similar settlements between the Justice Department and major hospitals that have offered transgender procedures to minors. In recent months, other significant institutions, such as Texas Children’s Hospital, the Cleveland Clinic Foundation, and Connecticut Children’s Hospital, have also agreed to halt youth transgender procedures. This pattern suggests a concerted effort by the federal government to reshape the landscape of pediatric gender care.

Executive order shapes administration’s policy

Shortly after taking office, President Donald Trump issued an executive order titled “Protecting Children from Chemical and Surgical Mutilation.” This order aims to defund federal support for gender reassignment procedures and directs the Justice Department to enforce existing laws against female genital mutilation. Furthermore, it mandates investigations into drug-safety violations and potential infringements on parental rights related to these treatments.

The executive order also instructed federal agencies to retract or modify policies that relied on guidance from the World Professional Association for Transgender Health (WPATH). WPATH is a professional association known for developing standards of care for transgender and gender-diverse patients. This directive highlights a direct challenge to the established medical guidelines that have informed many gender-affirming care programs across the nation.

WPATH guidelines under legal challenge

WPATH’s medical guidelines have historically served as the foundation for many hospitals’ protocols regarding transgender procedures, including those at Mount Sinai. Dr. Joshua Safer, executive director of the Mount Sinai Center for Transgender Medicine and Surgery, has notably co-authored WPATH guidelines, indicating the deep integration of these standards within the hospital’s former practices. The organization itself is currently facing legal action.

The Federal Trade Commission and several states have filed lawsuits against WPATH, alleging that the group made false and unsubstantiated claims regarding the safety, effectiveness, and medical necessity of pediatric medical-transition services. This ongoing case underscores the intensified legal and public scrutiny directed at the guidelines that underpin gender-affirming care for minors. While the specific details of the agreement with Mount Sinai were not publicly released by the Justice Department, the hospital acknowledged its cooperative and proactive approach throughout the investigation, stating the settlement reflects its commitment to patient confidentiality and clinician protection.